Top compounds associated with response to CBLN1


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC -0.054 0.4
mRNA paclitaxel gCSI pan-cancer AAC -0.048 0.4
mRNA MS-275 gCSI pan-cancer AAC 0.02 0.7
mRNA thapsigargin gCSI pan-cancer AAC -0.02 0.7
mRNA GDC-0941 gCSI pan-cancer AAC 0.004 0.9
mRNA Bortezomib gCSI pan-cancer AAC 0.0016 1
Download CSV